z-logo
open-access-imgOpen Access
Immunohistochemistry as a tool for screening rare renal cancers
Author(s) -
Cissy Yong,
Grant D. Stewart,
Christian Frezza
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.10.18
Subject(s) - immunohistochemistry , medicine , pathology
Recent additions of succinate dehydrogenase (SDH) and hereditary leiomyomatosis and renal cell cancer (HLRCC, associated) fumarate hydratase (FH)-deficient renal cell carcinomas (RCC) to the 2016 WHO Classification of Renal Tumours (1) have highlighted an evolving need for the distinction between renal cancer subtypes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom